[
  {
    "ts": "2025-09-29T17:30:44+00:00",
    "headline": "How Bristol-Myers Squibb Company (BMY) Delivers Strong Yields Even in Tough Markets",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 10 Best Recession Proof Dividend Stocks to Buy. Bristol-Myers Squibb Company (NYSE:BMY) is an American multinational pharmaceutical company. It concentrates primarily on branded pharmaceuticals, a sector known for high entry barriers and strong profitability. Developing breakthrough drugs requires billions in investment and years of research, with relatively few […]",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-173044837.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "a934a98e-31a1-3ae9-8e8d-9d1d1152b3a6",
      "content": {
        "id": "a934a98e-31a1-3ae9-8e8d-9d1d1152b3a6",
        "contentType": "STORY",
        "title": "How Bristol-Myers Squibb Company (BMY) Delivers Strong Yields Even in Tough Markets",
        "description": "",
        "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 10 Best Recession Proof Dividend Stocks to Buy. Bristol-Myers Squibb Company (NYSE:BMY) is an American multinational pharmaceutical company. It concentrates primarily on branded pharmaceuticals, a sector known for high entry barriers and strong profitability. Developing breakthrough drugs requires billions in investment and years of research, with relatively few […]",
        "pubDate": "2025-09-29T17:30:44Z",
        "displayTime": "2025-09-29T17:30:44Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "How Bristol-Myers Squibb Company (BMY) Delivers Strong Yields Even in Tough Markets",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w_.mq2hxLlg_y2nUTx72ng--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/t6o8Kx8kFVS_oEolQVNGNA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-173044837.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-173044837.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-29T13:11:05+00:00",
    "headline": "AbbVie to launch ovarian cancer drug in UK at US price",
    "summary": "President Donald Trump has been demanding that drugmakers align domestic prices with the lowest levels paid by comparable high-income countries under the \"most-favored-nation\" policy.  The U.S. pays nearly three times more for prescription drugs compared to other developed nations.  Last week, Bristol Myers Squibb said it planned to launch schizophrenia drug Cobenfy in the UK next year at a price matching its U.S. list price.",
    "url": "https://finance.yahoo.com/news/abbvie-launch-ovarian-cancer-drug-131105863.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "60cdb1a3-ba97-3aef-bd45-8de1fe1024c0",
      "content": {
        "id": "60cdb1a3-ba97-3aef-bd45-8de1fe1024c0",
        "contentType": "STORY",
        "title": "AbbVie to launch ovarian cancer drug in UK at US price",
        "description": "",
        "summary": "President Donald Trump has been demanding that drugmakers align domestic prices with the lowest levels paid by comparable high-income countries under the \"most-favored-nation\" policy.  The U.S. pays nearly three times more for prescription drugs compared to other developed nations.  Last week, Bristol Myers Squibb said it planned to launch schizophrenia drug Cobenfy in the UK next year at a price matching its U.S. list price.",
        "pubDate": "2025-09-29T13:11:05Z",
        "displayTime": "2025-09-29T13:11:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters-finance.com/b0886232216c65cf60b9fe05287b8b39",
          "originalWidth": 800,
          "originalHeight": 457,
          "caption": "Test tubes are seen in front of a displayed Abbvie logo in this illustration",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oc94zWHNmkuHXhDrdbYVEw--~B/aD00NTc7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters-finance.com/b0886232216c65cf60b9fe05287b8b39.cf.webp",
              "width": 800,
              "height": 457,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HLO3Q0kAFqvKlXkGbhRbEg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters-finance.com/b0886232216c65cf60b9fe05287b8b39.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "http://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-launch-ovarian-cancer-drug-131105863.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-launch-ovarian-cancer-drug-131105863.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]